Authors


Claire Hill

Latest:

Maximizing the Effectiveness of Upstream Bioprocessing Through the Combination of Lab Informatics and Instrumentation

By establishing effective management of data and knowledge, it will be possible to employ advances, such as artificial intelligence and synthetic biology, to their full potential in upstream bioprocessing.


Lyn Watson

Latest:

Dilution-Free Protein Concentration Measurement for High Protein Concentration Samples

Accurate protein concentration results can be obtained using standard spectrophotometers and commercially available short path length absorption cells.


Ajinmoto Bio-Pharma Services

Latest:

The Power to Make

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization, providing comprehensive process development services, cGMP manufacturing and drug product fill/finish services of small-molecule and biologic APIs and intermediates.


Brian Griffith

Latest:

Key Considerations When Outsourcing Cell-Culture Medium Development

The authors examine several issues that will help streamline negotiations between a service provider and a cell-culture medium consumer.


Bryan Haas

Latest:

Weighing Clinical Trial Outsourcing Options

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.


Manon M.J. Couture

Latest:

Plants As an Innovative and Accelerated Vaccine-Manufacturing Solution

A plant-based expression system could provide greater speed and capacity at a comparatively low cost.


Sanjib Bhattacharya

Latest:

Virosomes: A Novel Strategy for Drug Delivery and Targeting

Virosomes present novel drug-delivery vehicles with distinct advantages over liposomes.


Michael Eder, Biopharma Insights Contributor, Marketing Manager, Single Use Support

Latest:

Challenges in Bulk Drug Substance Management.

Final liquid drug substance production and fill–finish activities rarely occur at the same site. Nearly all pharmaceutical and biotechnology companies outsource a portion of their fill–finish needs to contract manufacturing organizations (CMOs) to help them address unexpected demand, satisfy second source policies, or better match scale with need.


Cytiva

Latest:

Top Tips for Successful Development of Antibody Chromatography Processes

In this interview, Jakob Liderfelt, Product Manager at Cytiva, discusses main challenges faced during chromatography process development for mAbs and mAb variants such as fragments and bispecific antibodies. Then, he shares his top tips for addressing challenges associated with mAb aggregates removal and separation of homo and heterodimers.


Dipanwita Batabyal

Latest:

Shaping IR Spectroscopy into a Powerful Tool for Biopharma Characterizations

In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.


David McElroy

Latest:

Biopharmaceutical Manufacturing and the Power of Synthetic Biology

Synthetic biology has advanced the scope and scale with which biologically derived therapeutics can be developed.


Mats Wikström

Latest:

Shaping IR Spectroscopy into a Powerful Tool for Biopharma Characterizations

In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.


Jeffrey Zonderman

Latest:

Shaping IR Spectroscopy into a Powerful Tool for Biopharma Characterizations

In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.


Libo Wang

Latest:

Shaping IR Spectroscopy into a Powerful Tool for Biopharma Characterizations

In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.



Yiming Peng

Latest:

Understanding Commercial Cell Culture Process Performance Variation Through Advanced Data Analytics

Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.


Jun Luo

Latest:

Understanding Commercial Cell Culture Process Performance Variation Through Advanced Data Analytics

Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.


Sid Kundu

Latest:

Understanding Commercial Cell Culture Process Performance Variation Through Advanced Data Analytics

Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.


Jesse Bergevin

Latest:

Understanding Commercial Cell Culture Process Performance Variation Through Advanced Data Analytics

Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.


Steve Gorfien

Latest:

Key Considerations When Outsourcing Cell-Culture Medium Development

The authors examine several issues that will help streamline negotiations between a service provider and a cell-culture medium consumer.


Joseph McLaughli

Latest:

Fermentation Process Technology Transfer for Production of a Recombinant Vaccine Component

The authors describe challenges faced in transfer and scale-up of a fermentation process.


Martin Samonig

Latest:

The Benefits of Combining UHPLC-UV and MS for Peptide Impurity Profiling

Determining a peptide’s purity is challenging because impurities are often structurally similar to each other and the API and can be present at very low concentrations. New approaches offer a solution.


Pranav Vengsarkar

Latest:

Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow

Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.


Nandu Deorkar

Latest:

Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow

Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.


Petra Nitschke, Biopharma Insights Contributor, Business Development CEVEC Pharmaceuticals GmbH

Latest:

ELEVECTA® - The Next Level in Gene Therapy AAV Production

Introduction of ELEVECTA®, CEVEC’s fully scalable and stable production platform for AAV gene therapy viral vector manufacturing.



Shamik Sharma

Latest:

Fermentation Process Technology Transfer for Production of a Recombinant Vaccine Component

The authors describe challenges faced in transfer and scale-up of a fermentation process.


Dave Agrella

Latest:

Weighing Clinical Trial Outsourcing Options

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.


Allen Basis

Latest:

Change and Innovation

BioPharm International is the longest-running peer-reviewed publication dedicated to your work.


Brian Trdina

Latest:

Supplier-Change Management for Drug-Product Manufacturers

An effective supplier-initiated change management process is discussed.

© 2025 MJH Life Sciences

All rights reserved.